Mark McClellan - Johnson Johnson Independent Director
JNJ Stock | EUR 135.72 0.44 0.33% |
Director
Dr. Mark B. McClellan, M.D., Ph.D. is an Independent Director of the Company. He became the inaugural Director of the DukeRobert J. Margolis, MD, Center for Health Policy and the Margolis Professor of Business, Medicine and Policy at Duke University in January 2016. He is also a faculty member at Dell Medical School at The University of Texas in Austin. Previously, he served from 2007 to 2015 as a Senior Fellow in Economic Studies and as Director of the Initiatives on Value and Innovation in Health Care at the Brookings Institution. Dr. McClellan served as Administrator of the Centers for Medicare Medicaid Services for the U.S. Department of Health and Human Services from 2004 to 2006 and as Commissioner of the U.S. Food and Drug Administration from 2002 to 2004. He served as a member of the Presidents Council of Economic Advisers and as senior director for healthcare policy at the White House from 2001 to 2002 and, during President Bill Clintons administration, held the position of Deputy Assistant Secretary for Economic Policy for the Department of the Treasury. Dr. McClellan previously served as an associate professor of economics and medicine with tenure at Stanford University, where he also directed the Program on Health Outcomes Research. Dr. McClellan is the founding chair and a current board member of the ReaganUdall Foundation for the Food and Drug Administration, is a member of the National Academy of Medicine and chairs the Academys Leadership Consortium for Value and ScienceDriven Health Care, and cochairs the guiding committee of the Health Care Payment Learning and Action Network. since 2013.
Age | 54 |
Tenure | 11 years |
Professional Marks | Ph.D |
Similar Executives
Showing other executives | DIRECTOR Age | ||
Anthony Saines | CarsalesCom | N/A | |
Edwina Gilbert | CarsalesCom | N/A | |
Michael Holmes | CarsalesCom | N/A | |
Donald Ehrlich | BG Foods | 80 | |
John Schwieters | BG Foods | 79 | |
Linda Filler | BG Foods | 58 | |
David Wiadrowski | CarsalesCom | N/A | |
Raymond Stevens | BG Foods | 55 | |
Alan Spoon | BG Foods | 67 | |
Kee Wong | CarsalesCom | N/A | |
Jeffrey Browne | CarsalesCom | 63 | |
Teri ListStoll | BG Foods | 56 | |
Chris Polites | CarsalesCom | N/A | |
Patrick OSullivan | CarsalesCom | 54 | |
Elias Zerhouni | BG Foods | 67 | |
Kim Anderson | CarsalesCom | N/A | |
Walter Lohr | BG Foods | 75 |
Johnson Johnson Leadership Team
Elected by the shareholders, the Johnson Johnson's board of directors comprises two types of representatives: Johnson Johnson inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Johnson. The board's role is to monitor Johnson Johnson's management team and ensure that shareholders' interests are well served. Johnson Johnson's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Johnson Johnson's outside directors are responsible for providing unbiased perspectives on the board's policies.
Jennifer Doudna, Independent Director | ||
Alex Gorsky, Chairman of the Board, CEO | ||
William Perez, Independent Director | ||
Michael Sneed, Executive Vice President - Global Corporate Affairs and Chief Communication Officer | ||
Marillyn Hewson, Independent Director | ||
Jorge Mesquita, Executive Vice President Worldwide Chairman - Consumer | ||
Mary Coleman, Independent Director | ||
Michael Ullmann, Vice President General Counsel | ||
Joaquin Duato, Executive Vice President Worldwide Chairman - Pharmaceuticals | ||
Kathy Wengel, Executive Vice President Chief Global Supply Chain Officer | ||
Jennifer Taubert, Executive Vice President - Worldwide Chairman, Pharmaceuticals | ||
Mary Beckerle, Director | ||
Sandra Peterson, Group Worldwide Chairman | ||
Scott Davis, Director | ||
Louise Mehrotra, Vice President Investor Relations | ||
Ashley McEvoy, Executive Vice President - Worldwide Chairman, Medical Devices | ||
Ronald Williams, Independent Director | ||
Kathryn Wengel, Executive Vice President Chief Global Supply Chain Officer | ||
Anne Mulcahy, Lead Independent Director | ||
Joseph Wolk, Vice President - Investor Relations | ||
Thibaut Mongon, Executive Vice President Worldwide Chairman, Consumer | ||
Ian Davis, Independent Director | ||
Paulus Stoffels, Chief Scientific Officer, Worldwide Chairman - Pharmaceuticals Group | ||
Mark McClellan, Independent Director | ||
Charles Prince, Independent Director | ||
Eugene Washington, Independent Director | ||
Dominic Caruso, CFO, Vice President - Finance | ||
Peter Fasolo, Vice President - Global Human Resources | ||
Susan Lindquist, Independent Director |
Johnson Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Johnson Johnson a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Current Valuation | 443.95 B | |||
Price To Book | 6.27 X | |||
Price To Sales | 4.97 X | |||
Revenue | 94.94 B | |||
EBITDA | 28.97 B | |||
Net Income | 17.94 B | |||
Total Debt | 26.89 B | |||
Cash Flow From Operations | 21.19 B | |||
Price To Earnings To Growth | 3.86 X | |||
Number Of Employees | 29 |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Johnson Johnson. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For more information on how to buy Johnson Stock please use our How to Invest in Johnson Johnson guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Johnson Stock analysis
When running Johnson Johnson's price analysis, check to measure Johnson Johnson's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Johnson Johnson is operating at the current time. Most of Johnson Johnson's value examination focuses on studying past and present price action to predict the probability of Johnson Johnson's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Johnson Johnson's price. Additionally, you may evaluate how the addition of Johnson Johnson to your portfolios can decrease your overall portfolio volatility.
Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
Money Managers Screen money managers from public funds and ETFs managed around the world | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Portfolio Anywhere Track or share privately all of your investments from the convenience of any device |